1. Assessment of relative bioavailability of two presentations of moroctocog alfa (AF‐CC) in subjects with moderately severe or severe hemophilia A. Issue 3 (27th October 2014) Authors: Shafer, Frank; Charnigo, Robert J.; Plotka, Anna; Baumann, James; Liang, Yali; Korth‐Bradley, Joan Journal: Clinical pharmacology in drug development Issue: Volume 4:Issue 3(2015:May/Jun.) Page Start: 237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative Pharmacokinetics and Pharmacodynamics of Bococizumab Following a Single Subcutaneous Injection Using Drug Substance Manufactured at Two Sites or Administration via Two Different Devices. Issue 1 (24th April 2018) Authors: Wang, Ellen Q.; Plotka, Anna; Salageanu, Joanne; Baltrukonis, Daniel; Mridha, Khurshid; Frederich, Robert; Sullivan, Beth E. Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 1(2019) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intravenous Rivipansel. Issue 8 (24th June 2020) Authors: Tammara, Brinda K.; Ryan, Kelly; Plotka, Anna; Shafer, Frank E.; Wei, Hua; Readett, David; Fang, Annie; Korth‐Bradley, Joan M. Journal: Clinical pharmacology in drug development Issue: Volume 9:Issue 8(2020) Page Start: 918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evaluation of pharmacokinetics and safety of talazoparib in patients with advanced cancer and varying degrees of hepatic impairment. Issue 7 (18th March 2022) Authors: Guo, Cen; Yu, Yanke; Chakrabarti, Jayeta; Piha‐Paul, Sarina A.; Moroose, Rebecca; Plotka, Anna; Shi, Haihong; Durairaj, Chandrasekar; Wang, Diane D.; Wainberg, Zev A. Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 7(2022) Page Start: 3392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evaluation of the effect of P‐glycoprotein inhibition and induction on talazoparib disposition in patients with advanced solid tumours. Issue 4 (7th January 2020) Authors: Elmeliegy, Mohamed; Láng, István; Smolyarchuk, Elena A.; Chung, Chin‐Hee; Plotka, Anna; Shi, Haihong; Wang, Diane Journal: British journal of clinical pharmacology Issue: Volume 86:Issue 4(2020) Page Start: 771 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of Acid‐Reducing Agents on the Pharmacokinetics of Palbociclib, a Weak Base With pH‐Dependent Solubility, With Different Food Intake Conditions. Issue 6 (21st April 2017) Authors: Sun, Wan; Klamerus, Karen J.; Yuhas, Lisa M.; Pawlak, Sylvester; Plotka, Anna; O'Gorman, Melissa; Kirkovsky, Leonid; Kosa, Maha; Wang, Diane Journal: Clinical pharmacology in drug development Issue: Volume 6:Issue 6(2017) Page Start: 614 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Lack of Effect of Rivipansel on QTc Interval in Healthy Adult African American Male Subjects. (16th May 2017) Authors: Tammara, Brinda K.; Plotka, Anna; Shafer, Frank E.; Readett, David R. J.; Riley, Steve; Korth‐Bradley, Joan M. Journal: Journal of clinical pharmacology Issue: Volume 57:Number 10(2017) Page Start: 1315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacokinetics and pharmacodynamics of bococizumab, a monoclonal antibody to PCSK9, after single subcutaneous injection at three sites [NCT 02043301]. Issue 5 (14th September 2017) Authors: Wang, Ellen Q.; Plotka, Anna; Salageanu, Joanne; Sattler, Catherine; Yunis, Carla Journal: Cardiovascular therapeutics Issue: Volume 35:Issue 5(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pharmacokinetics, pharmacodynamics, and safety of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, in healthy subjects when administered in co‐mixture with recombinant human hyaluronidase: A phase 1 randomized trial. Issue 9 (18th July 2018) Authors: Bass, Almasa; Plotka, Anna; Mridha, Khurshid; Sattler, Catherine; Kim, Albert M.; Plowchalk, David R. Journal: Health science reports Issue: Volume 1:Issue 9(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Talazoparib has no clinically relevant effect on QTc interval in patients with advanced solid tumors. Issue 5 (June 2019) Authors: Hoffman, Justin; Chakrabarti, Jayeta; Plotka, Anna; Milillo Naraine, Adriana; Kanamori, David; Moroose, Rebecca; Nguyen, Linh; Wang, Diane; Wainberg, Zev A. Journal: Anti-cancer drugs Issue: Volume 30:Issue 5(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗